This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Real World Asparaginase Therapy Toxicity | MicrobiomeTrials
← Back to trials NCT07008027
Real World Asparaginase Therapy Toxicity Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-11Est. Completion: 2030-07
Enrollment target: 200 participantsLocations St. Jude Children's Research Hospital, Memphis, Tennessee, United States Other microbiome trials you might be interested in Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020
Rifampicin-Resistant Pulmonary Tuberculosis
Multidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, China Est. completion Sep 29, 2028
Relapsed Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia B-cell Acute Lymphoblastic Leukemia Pediatric Cancer Pediatric ALL, Relapsed Pediatric ALL Pediatric ALL, B Cell Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Pediatric AML R/R AML R/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple Locations Est. completion Apr 30, 2030